Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista colombiana de Gastroenterología
Print version ISSN 0120-9957
Abstract
NARCISO-SCHIAVON, Janaína Luz et al. Recurrent albendazole-induced acute hepatitis. Rev Col Gastroenterol [online]. 2018, vol.33, n.4, pp.473-477. ISSN 0120-9957. https://doi.org/10.22516/25007440.206.
Albendazole is used to treat helminth infections and usually has minimal or no side effects. A transient increase in liver enzymes is common following its use, but little evidence of albendazole-induced liver damage has been reported in the literature. This study presents a patient who developed acute hepatitis following self-medication with albendazole. The patient also had a history of similar episodes in the past after using the drug. After a thorough investigation and exclusion of all other causes of the patient’s clinical condition, the Roussel Uclaf Causality Assessment Method of the Council for International Organizations of Medical Sciences scale yielded a score of 10 points, indicating a high probability of albendazole-induced liver damage. In conclusion, expediting the process of combating helminths is ideal, but quality monitoring is required to avoid adverse reactions such as drug-induced hepatitis. Moreover, self-medication with any drug should always be discouraged.
Keywords : Drug-Induced Liver Injury; Albendazole; Alanine transaminase.